Thank you very much, Mr. Chairman.
Allow me to thank all of the witnesses today for their very interesting and troubling testimony about the situation that now exists, what we're looking forward to in the next number of months, and perhaps in the longer term. I have some more questions about some of this.
Dr. Urbain, first of all, you've talked about the impact of this on clinics across the country. In terms of a typical patient, whether they are receiving cardiac care or cancer treatment, what does the next six months look like, first of all in relation to supply, and secondly in relation to what it means for patients?